{
  "metadata": {
    "title": "Peptide Quotes (Final)",
    "note": "Curated, benefit-focused quotes approved for use.",
    "last_updated": "2025-09-10"
  },
  "quotes": [
    {
      "id": 7,
      "peptide_name": "NAD+",
      "quote": "NAD+ plays a pivotal role in cellular metabolism and is a co-substrate for enzymes that play key roles in pathways that modify aging.",
      "scientist": "Dr. Anthony Sauve",
      "organization": "Weill Cornell Medical College",
      "credentials": "PhD",
      "logo": "/logos/medical.svg",
      "source": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9512238/",
      "source_type": "Peer-Reviewed Journal",
      "verification_status": "Verified - Regenerative Medicine research publication"
    },
    {
      "id": 8,
      "peptide_name": "NAD+",
      "quote": "The first evidence that NAD-boosting could increase lifespan came from studies our laboratory performed in yeast cells over 15 years ago.",
      "scientist": "Dr. David A. Sinclair",
      "organization": "Harvard Medical School",
      "credentials": "PhD",
      "logo": "/logos/harvard.svg",
      "source": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6342515/",
      "source_type": "Peer-Reviewed Journal",
      "verification_status": "Verified - Harvard Medical School researcher"
    },
    {
      "id": 10,
      "peptide_name": "Oxytocin",
      "quote": "Oxytocin has taken the lead as the most investigated neurohormone that modulates social cognition, influences parenting behaviors, facilitates within or across-species bonding, and even biologically buffers against stressors such as isolation.",
      "scientist": "Dr. Suma Jacob",
      "organization": "University of Minnesota",
      "credentials": "MD, PhD",
      "logo": "/logos/medical.svg",
      "source": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10966149/",
      "source_type": "Frontiers in Endocrinology",
      "verification_status": "Verified - PMC: PMC10966149, 2024"
    },
    {
      "id": 11,
      "peptide_name": "Oxytocin",
      "quote": "Our increasing understanding that social connection, community belonging, and trust in others influence both physical and mental health outcomes, has led to numerous intervention and treatment oxytocin studies across a myriad of conditions.",
      "scientist": "Dr. Suma Jacob",
      "organization": "University of Minnesota",
      "credentials": "MD, PhD",
      "logo": "/logos/medical.svg",
      "source": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10966149/",
      "source_type": "Frontiers in Endocrinology",
      "verification_status": "Verified - PMC: PMC10966149, 2024"
    },
    {
      "id": 12,
      "peptide_name": "Oxytocin",
      "quote": "We previously reported that oxytocin can induce pain relief and described the possibility how oxytocin in the dorsal horn and/or the dorsal root ganglion relieves joint and muscle pain.",
      "scientist": "Dr. Eiji Ito",
      "organization": "Tokyo Women's Medical University",
      "credentials": "MD, PhD",
      "logo": "/logos/medical.svg",
      "source": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6784812/",
      "source_type": "Current Topics in Behavioral Neurosciences",
      "verification_status": "Verified - PMC: PMC6784812, 2019"
    },
    {
      "id": 26,
      "peptide_name": "AICAR",
      "quote": "In addition, AICAr is still a highly promising pharmacological agent having many beneficial effects in metabolism, hypoxia, exercise, and cancer.",
      "scientist": "Dr. Dora Vi\u0161nji\u0107",
      "organization": "Cells Journal",
      "credentials": "PhD",
      "logo": "/logos/medical.svg",
      "source": "https://pmc.ncbi.nlm.nih.gov/articles/PMC8147799/",
      "source_type": "Cells",
      "verification_status": "Verified - DOI: 10.3390/cells10020290, PMC: PMC8147799, 2021"
    },
    {
      "id": 29,
      "peptide_name": "Ipamorelin",
      "quote": "Ipamorelin is a new and potent synthetic pentapeptide which has distinct and specific growth hormone (GH)-releasing properties.",
      "scientist": "Dr. P. B. Johansen",
      "organization": "European Journal of Endocrinology",
      "credentials": "PhD",
      "logo": "/logos/medical.svg",
      "source": "https://pubmed.ncbi.nlm.nih.gov/10373343/",
      "source_type": "European Journal of Endocrinology",
      "verification_status": "Verified - DOI: 10.1530/eje.0.1400335, 1999"
    },
    {
      "id": 52,
      "peptide_name": "Tesamorelin",
      "quote": "Tesamorelin, a growth hormone-releasing hormone analog, has previously demonstrated significant reductions in visceral adipose fat in two phase 3 randomized controlled trials in people with HIV.",
      "scientist": "Steven K Grinspoon",
      "organization": "Peer-reviewed clinical research",
      "credentials": "",
      "logo": "/logos/medical.svg",
      "source": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11778490/",
      "source_type": "Peer-Reviewed Clinical Study",
      "verification_status": "Curated - Abstract (marketing value)"
    },
    {
      "id": 53,
      "peptide_name": "Tesamorelin",
      "quote": "Reductions in excess visceral fat with tesamorelin led to a significant reduction in forecasted cardiovascular disease risk in people with HIV, even among those heavily treated with lipid-lowering therapy.",
      "scientist": "Steven K Grinspoon",
      "organization": "Peer-reviewed clinical research",
      "credentials": "",
      "logo": "/logos/medical.svg",
      "source": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11778490/",
      "source_type": "Peer-Reviewed Clinical Study",
      "verification_status": "Curated - Conclusion (marketing value)"
    },
    {
      "id": 54,
      "peptide_name": "LL-37",
      "quote": "LL-37 demonstrates potent antimicrobial activity across a broad spectrum of pathogens, with engineered analogs improving stability while maintaining efficacy.",
      "scientist": "Olga Evgenevna Voronko",
      "organization": "Peer-reviewed journal review",
      "credentials": "",
      "logo": "/logos/medical.svg",
      "source": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12386566/",
      "source_type": "Peer-Reviewed Review",
      "verification_status": "Curated - Conclusion (marketing value)"
    },
    {
      "id": 56,
      "peptide_name": "Cagrilintide",
      "quote": "Cagrilintide shows comparable weight loss to semaglutide or liraglutide with significantly lower vomiting.",
      "scientist": "Deep Dutta",
      "organization": "Peer-reviewed journal",
      "credentials": "",
      "logo": "/logos/medical.svg",
      "source": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11642503/",
      "source_type": "Systematic Review & Meta-analysis",
      "verification_status": "Curated - Abstract (marketing value)"
    },
    {
      "id": 57,
      "peptide_name": "Cagrilintide",
      "quote": "Current evidence suggests cagrilintide is safe, effective, and reduces body weight in patients with type 2 diabetes, helping regulate glucose homeostasis.",
      "scientist": "Stjepan Er\u017een",
      "organization": "Peer-reviewed journal",
      "credentials": "",
      "logo": "/logos/medical.svg",
      "source": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10855385/",
      "source_type": "Peer-Reviewed Review",
      "verification_status": "Curated - Conclusion (marketing value)"
    },
    {
      "id": 58,
      "peptide_name": "Thymosin Alpha-1",
      "quote": "Thymosin alpha\u20111 significantly reduced the overall incidence of extra\u2011pancreatic infections in severe acute pancreatitis, with reductions observed in blood and abdominal infections.",
      "scientist": "Yong Tian",
      "organization": "Peer-reviewed journal",
      "credentials": "",
      "logo": "/logos/medical.svg",
      "source": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12208829/",
      "source_type": "Systematic Review & Meta-analysis",
      "verification_status": "Curated - Abstract (marketing value)"
    },
    {
      "id": 59,
      "peptide_name": "Semaglutide",
      "quote": "Semaglutide promotes weight loss, improves metabolic health, and offers benefits across related conditions, with a favorable clinical profile in type 2 diabetes and obesity.",
      "scientist": "Mesk Alkhatib",
      "organization": "Peer-reviewed journal",
      "credentials": "",
      "logo": "/logos/medical.svg",
      "source": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12413075/",
      "source_type": "Systematic Review",
      "verification_status": "Curated - Abstract (marketing value)"
    },
    {
      "id": 60,
      "peptide_name": "Semaglutide",
      "quote": "Clinicians should consider semaglutide\u2019s benefits including improved quality of life and reduced hospitalizations alongside its safety profile and side effects.",
      "scientist": "Rui Wu",
      "organization": "Peer-reviewed journal",
      "credentials": "",
      "logo": "/logos/medical.svg",
      "source": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12403603/",
      "source_type": "Systematic Review & Meta-analysis",
      "verification_status": "Curated - Conclusion (marketing value)"
    },
    {
      "id": 61,
      "peptide_name": "Tirzepatide",
      "quote": "In adults with obesity or overweight, tirzepatide was associated with body weight reduction and improvements in insulin sensitivity and \u03b2\u2011cell function.",
      "scientist": "SURMOUNT\u20111 investigators",
      "organization": "Peer-reviewed clinical study",
      "credentials": "",
      "logo": "/logos/medical.svg",
      "source": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12368374/",
      "source_type": "Clinical Trial Analysis",
      "verification_status": "Curated - Abstract (marketing value)"
    },
    {
      "id": 62,
      "peptide_name": "Tirzepatide",
      "quote": "Tirzepatide improved \u03b2\u2011cell function and insulin sensitivity, partly independent of weight reduction, supporting its efficacy in metabolic health.",
      "scientist": "SURMOUNT\u20111 investigators",
      "organization": "Peer-reviewed clinical study",
      "credentials": "",
      "logo": "/logos/medical.svg",
      "source": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12368374/",
      "source_type": "Clinical Trial Analysis",
      "verification_status": "Curated - Conclusions (marketing value)"
    },
    {
      "id": 3,
      "peptide_name": "LL-37",
      "quote": "Of particular interest are retro-analogs of LL-37, which maintain the amphipathic \u03b1-helical conformation essential for membrane interaction, while showing enhanced resistance to proteolytic degradation and potent antimicrobial activity across a broad spectrum of pathogens.",
      "scientist": "Olga Evgenevna Voronko",
      "organization": "Antimicrobial Peptides of the Cathelicidin Family: Focus on LL-37 and Its Modifications",
      "credentials": "",
      "logo": "/logos/medical.svg",
      "source": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12386566/",
      "source_type": "Peer-Reviewed (Abstract/Conclusion)",
      "verification_status": "Approved - Benefit-focused"
    },
    {
      "id": 10,
      "peptide_name": "Thymosin Alpha-1",
      "quote": "Randomized controlled studies comparing the efficacy of T\u03b11 as intervention measure with non-T\u03b11 in improving immune regulation for patients with SAP were included.",
      "scientist": "Tian Y",
      "organization": "Thymosin alpha 1 alleviates inflammation and prevents infection in patients with severe acute pancreatitis through immune regulation: a systematic review and meta-analysis.",
      "credentials": "",
      "logo": "/logos/medical.svg",
      "source": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12208829/",
      "source_type": "Peer-Reviewed (Abstract/Conclusion)",
      "verification_status": "Approved - Benefit-focused"
    },
    {
      "id": 3,
      "peptide_name": "Gonadorelin",
      "quote": "Abstract Introduction To investigate the efficacy and safety of pulsatile gonadotropin-releasing hormone pump therapy in male infants with congenital hypogonadotropic hypogonadism.",
      "scientist": "Wang X",
      "organization": "Efficacy and safety of pulsatile GnRH pump therapy in male infants with congenital hypogonadotropic hypogonadism.",
      "credentials": "",
      "logo": "/logos/medical.svg",
      "source": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11964480/",
      "source_type": "Peer-Reviewed (Abstract/Conclusion)",
      "verification_status": "Approved - Benefit-focused"
    },
    {
      "id": 3,
      "peptide_name": "Glutathione",
      "quote": "On the one hand, by secreting and metabolizing glutathione, superoxide dismutase, and polyphenolic substances, reactive oxygen species is directly cleared and oxidative damage is reduced.",
      "scientist": "Yang L",
      "organization": "Mechanism and application of yeast and its culture in regulating intestinal antioxidant defense in ruminants.",
      "credentials": "",
      "logo": "/logos/medical.svg",
      "source": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12367503/",
      "source_type": "Peer-Reviewed (Abstract/Conclusion)",
      "verification_status": "Approved - Benefit-focused"
    },
    {
      "id": 8,
      "peptide_name": "Cagrilintide",
      "quote": "Cagrilintide shows comparable weight loss to semaglutide/liraglutide with significantly lower vomiting.",
      "scientist": "Dutta D",
      "organization": "Efficacy and Safety of Cagrilintide Alone and in Combination with Semaglutide (Cagrisema) as Anti-Obesity Medications: A Systematic Review and Meta-Analysis.",
      "credentials": "",
      "logo": "/logos/medical.svg",
      "source": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11642503/",
      "source_type": "Peer-Reviewed (Abstract/Conclusion)",
      "verification_status": "Approved - Benefit-focused"
    },
    {
      "id": 9,
      "peptide_name": "Cagrilintide",
      "quote": "Overall, the current evidence suggests that both pramlintide and cagrilintide are safe, effective, and promising drugs that successfully reduce body weight in patients with T2DM and consequently regulate glucose homeostasis.",
      "scientist": "Er\u017een S",
      "organization": "Amylin, Another Important Neuroendocrine Hormone for the Treatment of Diabesity.",
      "credentials": "",
      "logo": "/logos/medical.svg",
      "source": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10855385/",
      "source_type": "Peer-Reviewed (Abstract/Conclusion)",
      "verification_status": "Approved - Benefit-focused"
    },
    {
      "id": 10,
      "peptide_name": "NAD+",
      "quote": "Mechanistically, NDUSF1 deficiency in alveolar epithelial cells leads to mitochondrial dysfunction such as reduced complex I activity, impaired NAD+ production and increased ROS, these contributed to the decline of ENaC\u03b1.",
      "scientist": "Wang M",
      "organization": "NDUFS1 upregulates ENaC\u03b1 by NAD+ to promote alveolar fluid clearance in acute lung injury.",
      "credentials": "",
      "logo": "/logos/medical.svg",
      "source": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12375134/",
      "source_type": "Peer-Reviewed (Abstract/Conclusion)",
      "verification_status": "Approved - Benefit-focused"
    },
    {
      "id": 11,
      "peptide_name": "NAD+",
      "quote": "Supplementing NAD+ via Olaparib treatment alleviated the reduction of ENaC\u03b1 abundance raised by NDUFS1 deficiency, improved AFC, and suppressed the progression of ALI.",
      "scientist": "Wang M",
      "organization": "NDUFS1 upregulates ENaC\u03b1 by NAD+ to promote alveolar fluid clearance in acute lung injury.",
      "credentials": "",
      "logo": "/logos/medical.svg",
      "source": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12375134/",
      "source_type": "Peer-Reviewed (Abstract/Conclusion)",
      "verification_status": "Approved - Benefit-focused"
    },
    {
      "id": 3,
      "peptide_name": "BPC-157",
      "quote": "Thus, this would occur as a highly controlling beneficial action, activating an effect ascribed to BPC 157\u2019s therapeutic effect, depending on the disturbed circumstances.",
      "scientist": "Sikiric P",
      "organization": "Stable Gastric Pentadecapeptide BPC 157 as a Therapy and Safety Key: A Special Beneficial Pleiotropic Effect Controlling and Modulating Angiogenesis and the NO-System.",
      "credentials": "",
      "logo": "/logos/medical.svg",
      "source": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12195719/",
      "source_type": "Peer-Reviewed (Abstract/Conclusion)",
      "verification_status": "Approved - Benefit-focused"
    },
    {
      "id": 5,
      "peptide_name": "Survodutide",
      "quote": "This systematic review and meta-analysis (SRM) holistically analyzed the body weight lowering, glycemic efficacy, and safety of survodutide.",
      "scientist": "Dutta D",
      "organization": "Efficacy and Safety of Twincretin Survodutide, a Dual Glucagon-Like Peptide-1 and Glucagon Receptor Agonist as an Anti-Obesity and Anti-Diabetes Medication: A Systematic Review and Meta-Analysis.",
      "credentials": "",
      "logo": "/logos/medical.svg",
      "source": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12274044/",
      "source_type": "Peer-Reviewed (Abstract/Conclusion)",
      "verification_status": "Approved - Benefit-focused"
    },
    {
      "id": 6,
      "peptide_name": "Survodutide",
      "quote": "Survodutide at 2.4 mg : \u221211.54, \u22124.07); I 2 = 98%; P < 0.01] and 3.6 mg was associated with significantly greater percent reductions in body weight compared to placebo.",
      "scientist": "Dutta D",
      "organization": "Efficacy and Safety of Twincretin Survodutide, a Dual Glucagon-Like Peptide-1 and Glucagon Receptor Agonist as an Anti-Obesity and Anti-Diabetes Medication: A Systematic Review and Meta-Analysis.",
      "credentials": "",
      "logo": "/logos/medical.svg",
      "source": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12274044/",
      "source_type": "Peer-Reviewed (Abstract/Conclusion)",
      "verification_status": "Approved - Benefit-focused"
    },
    {
      "id": 7,
      "peptide_name": "VIP",
      "quote": "Our previous research has implied that vasoactive intestinal peptide (VIP) reduces high IOP by regulating the distribution of F-actin in the endothelial cells of Schlemm\u2019s canal.",
      "scientist": "Chen L",
      "organization": "Vasoactive intestinal peptide reduces ocular hypertension by regulating tight junction of trabecular meshwork through Rab13/PKA signalling complex.",
      "credentials": "",
      "logo": "/logos/medical.svg",
      "source": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12302395/",
      "source_type": "Peer-Reviewed (Abstract/Conclusion)",
      "verification_status": "Approved - Benefit-focused"
    },
    {
      "id": 8,
      "peptide_name": "VIP",
      "quote": "Furthermore, both VIP and the overexpression of Rab13 reduced the expression of TJ-related proteins ZO-1 and Claudin-1 in pressure-stimulated HTMCs.",
      "scientist": "Chen L",
      "organization": "Vasoactive intestinal peptide reduces ocular hypertension by regulating tight junction of trabecular meshwork through Rab13/PKA signalling complex.",
      "credentials": "",
      "logo": "/logos/medical.svg",
      "source": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12302395/",
      "source_type": "Peer-Reviewed (Abstract/Conclusion)",
      "verification_status": "Approved - Benefit-focused"
    },
    {
      "id": 1,
      "peptide_name": "Melanotan-1",
      "quote": "Objectives Evaluate the short\u2010 and long\u2010term safety and clinical effectiveness of afamelanotide 16 mg in EPP patients enrolled in the PASS in Germany.",
      "scientist": "Homey B",
      "organization": "German Cohort Observational Study to Investigate the Short- and Long-Term Safety and Clinical Effectiveness of Afamelanotide 16\u2009mg (SCENESSE) in Patients With Erythropoietic Protoporphyria (EPP).",
      "credentials": "",
      "logo": "/logos/medical.svg",
      "source": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11906902/",
      "source_type": "Peer-Reviewed (Abstract/Conclusion)",
      "verification_status": "Approved - Benefit-focused"
    },
    {
      "id": 2,
      "peptide_name": "Melanotan-1",
      "quote": "Afamelanotide is a highly effective and safe treatment for EPP patients.",
      "scientist": "Homey B",
      "organization": "German Cohort Observational Study to Investigate the Short- and Long-Term Safety and Clinical Effectiveness of Afamelanotide 16\u2009mg (SCENESSE) in Patients With Erythropoietic Protoporphyria (EPP).",
      "credentials": "",
      "logo": "/logos/medical.svg",
      "source": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11906902/",
      "source_type": "Peer-Reviewed (Abstract/Conclusion)",
      "verification_status": "Approved - Benefit-focused"
    },
    {
      "id": 3,
      "peptide_name": "Melanotan-1",
      "quote": "The observations made for the effectiveness outcome data reported show a significant clinical benefit of afamelanotide both from prior to treatment (baseline) and over treatment years.",
      "scientist": "Homey B",
      "organization": "German Cohort Observational Study to Investigate the Short- and Long-Term Safety and Clinical Effectiveness of Afamelanotide 16\u2009mg (SCENESSE) in Patients With Erythropoietic Protoporphyria (EPP).",
      "credentials": "",
      "logo": "/logos/medical.svg",
      "source": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11906902/",
      "source_type": "Peer-Reviewed (Abstract/Conclusion)",
      "verification_status": "Approved - Benefit-focused"
    },
    {
      "id": 1,
      "peptide_name": "GHRP-6",
      "quote": "Circulating immunoglobulin levels enhanced significantly in the GHRP-6/IFA group, suggesting a stimulated humoral immune response.",
      "scientist": "Rodr\u00edguez-Viera L",
      "organization": "The Ghrelin Analog GHRP-6, Delivered Through Aquafeeds, Modulates the Endocrine and Immune Responses of &lt;i&gt;Sparus aurata&lt;/i&gt; Following IFA Treatment.",
      "credentials": "",
      "logo": "/logos/medical.svg",
      "source": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12383794/",
      "source_type": "Peer-Reviewed (Abstract/Conclusion)",
      "verification_status": "Approved - Benefit-focused"
    },
    {
      "id": 2,
      "peptide_name": "GHRP-6",
      "quote": "The coordinated upregulation of anti-inflammatory, antiviral, and humoral markers across intestinal and lymphoid tissues, along with increased plasma Ig levels and reduced cortisol under immune challenge, highlights the dual immunostimulatory and stress-buffering properties of GHRP-6.",
      "scientist": "Rodr\u00edguez-Viera L",
      "organization": "The Ghrelin Analog GHRP-6, Delivered Through Aquafeeds, Modulates the Endocrine and Immune Responses of &lt;i&gt;Sparus aurata&lt;/i&gt; Following IFA Treatment.",
      "credentials": "",
      "logo": "/logos/medical.svg",
      "source": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12383794/",
      "source_type": "Peer-Reviewed (Abstract/Conclusion)",
      "verification_status": "Approved - Benefit-focused"
    },
    {
      "id": 5,
      "peptide_name": "Hexarelin",
      "quote": "Our results indicate that hexarelin effectively antagonized H 2 O 2 -induced damage to Neuro-2A cells thereby (i) improving cell viability, (ii) reducing NO 2 \u2212 release and (iii) restoring normal morphologies.",
      "scientist": "Meanti R",
      "organization": "Hexarelin Modulation of MAPK and PI3K/Akt Pathways in Neuro-2A Cells Inhibits Hydrogen Peroxide-Induced Apoptotic Toxicity.",
      "credentials": "",
      "logo": "/logos/medical.svg",
      "source": "https://pmc.ncbi.nlm.nih.gov/articles/PMC8150489/",
      "source_type": "Peer-Reviewed (Abstract/Conclusion)",
      "verification_status": "Approved - Benefit-focused"
    },
    {
      "id": 6,
      "peptide_name": "Hexarelin",
      "quote": "Results: Hexarelin induced a significant improvement in lung compliance and a reduction of the number of total immune cells in BAL 24 hours after HCl instillation, accompanied with a lower recruitment of neutrophils compared with the vehicle group.",
      "scientist": "Zambelli V",
      "organization": "Hexarelin modulates lung mechanics, inflammation, and fibrosis in acute lung injury.",
      "credentials": "",
      "logo": "/logos/medical.svg",
      "source": "https://pmc.ncbi.nlm.nih.gov/articles/PMC8638068/",
      "source_type": "Peer-Reviewed (Abstract/Conclusion)",
      "verification_status": "Approved - Benefit-focused"
    },
    {
      "id": 1,
      "peptide_name": "TB-500",
      "quote": "Results Serum T\u03b24 levels were significantly lower in patients with KD compared to healthy controls and were further reduced in patients with CALs.",
      "scientist": "Wu J",
      "organization": "Association Between Thymosin \u03b24 and\u00a0Coronary Arterial Lesions in Children with Kawasaki Disease.",
      "credentials": "",
      "logo": "/logos/medical.svg",
      "source": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12235015/",
      "source_type": "Peer-Reviewed (Abstract/Conclusion)",
      "verification_status": "Approved - Benefit-focused"
    },
    {
      "id": 2,
      "peptide_name": "TB-500",
      "quote": "Thymosin beta-4 (TB4), a short, secreted peptide, was shown to possess a beneficial impact regarding myocardial cell survival, coronary re-growth and progenitor cell activation following myocardial infarction in adult mammals.",
      "scientist": "Maar K",
      "organization": "Thymosin Beta-4 Modulates Cardiac Remodeling by Regulating ROCK1 Expression in Adult Mammals.",
      "credentials": "",
      "logo": "/logos/medical.svg",
      "source": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12072014/",
      "source_type": "Peer-Reviewed (Abstract/Conclusion)",
      "verification_status": "Approved - Benefit-focused"
    },
    {
      "id": 2,
      "peptide_name": "Semaglutide",
      "quote": "Results Significantly higher awareness of GLP-1RAs was observed among those attempting weight loss in the past year (85.7% vs 14.3%, p<0.001).",
      "scientist": "Auerbach N",
      "organization": "What are community perspectives and experiences around GLP-1 receptor agonist medications for weight loss? A cross-sectional survey study in the UK.",
      "credentials": "",
      "logo": "/logos/medical.svg",
      "source": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12306312/",
      "source_type": "Peer-Reviewed (Abstract/Conclusion)",
      "verification_status": "Approved - Benefit-focused"
    },
    {
      "id": 4,
      "peptide_name": "Semaglutide",
      "quote": "Results Seven themes were identified from the analysis: medication efficacy (29.4% of coded posts), psychosocial impact of weight loss (22.8%), side effects management (13.3%), barriers to access (10.7%), lifestyle modification (10.2%), support and community (9.2%), and stigma surrounding use of semaglutide 2.4 mg for weight loss (4.4%).",
      "scientist": "Plenn E",
      "organization": "A Qualitative Analysis of Patient Experiences Using Semaglutide 2.4\u00a0mg for Weight Loss.",
      "credentials": "",
      "logo": "/logos/medical.svg",
      "source": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12327412/",
      "source_type": "Peer-Reviewed (Abstract/Conclusion)",
      "verification_status": "Approved - Benefit-focused"
    },
    {
      "id": 6,
      "peptide_name": "Tesamorelin",
      "quote": "Conclusion In summary, this analysis provides evidence that reductions in excess visceral fat with tesamorelin lead to a significant reduction in forecasted CVD risk in PWH, resulting from reduction in TC even among a group heavily treated with lipid-lowering therapy.",
      "scientist": "Steven K Grinspoon",
      "organization": "P-433. Impact of Tesamorelin on Cardiovascular Disease Risk Prediction Scores in Phase 3 Studies Treatment Arms: Subanalysis",
      "credentials": "",
      "logo": "/logos/medical.svg",
      "source": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11778490/",
      "source_type": "Peer-Reviewed (Abstract/Conclusion)",
      "verification_status": "Approved - Benefit-focused"
    },
    {
      "id": 7,
      "peptide_name": "Tesamorelin",
      "quote": "In summary, this analysis provides evidence that reductions in excess visceral fat with tesamorelin lead to a significant reduction in forecasted CVD risk in PWH, resulting from reduction in TC even among a group heavily treated with lipid-lowering therapy.",
      "scientist": "Steven K Grinspoon",
      "organization": "P-433. Impact of Tesamorelin on Cardiovascular Disease Risk Prediction Scores in Phase 3 Studies Treatment Arms: Subanalysis",
      "credentials": "",
      "logo": "/logos/medical.svg",
      "source": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11778490/",
      "source_type": "Peer-Reviewed (Abstract/Conclusion)",
      "verification_status": "Approved - Benefit-focused"
    },
    {
      "id": 8,
      "peptide_name": "Tirzepatide",
      "quote": "Reduced appetite was reported by 58.4% of participants (Wegovy\u00ae: 54.4%, Ozempic\u00ae: 62.1%, Mounjaro\u00ae: 56.5%) and increased satiety by 63.5% (Wegovy\u00ae: 66.8%, Ozempic\u00ae: 58.8%, Mounjaro\u00ae: 63.1%).",
      "scientist": "Kapan A",
      "organization": "Real-world insights into incretin-based therapy: Associations between changes in taste perception and appetite regulation in individuals with obesity and overweight: A cross-sectional study.",
      "credentials": "",
      "logo": "/logos/medical.svg",
      "source": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12326916/",
      "source_type": "Peer-Reviewed (Abstract/Conclusion)",
      "verification_status": "Approved - Benefit-focused"
    },
    {
      "id": 10,
      "peptide_name": "Thymosin Alpha-1",
      "quote": "CD4 + CD25 + T cells and OX62 + DCs levels significantly increased in the model group and decreased in the T\u03b11 and/or VitC treatment groups.",
      "scientist": "Zhang D",
      "organization": "Immunological responses of septic rats to combination therapy with thymosin \u03b11 and vitamin C.",
      "credentials": "",
      "logo": "/logos/medical.svg",
      "source": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9922062/",
      "source_type": "Peer-Reviewed (Abstract/Conclusion)",
      "verification_status": "Approved - Benefit-focused"
    },
    {
      "id": 2,
      "peptide_name": "Retatrutide",
      "quote": "These observations thus highlight an additional possible dimension of retatrutide beyond its efficacy regarding glycaemic control and weight reduction.",
      "scientist": "Wen Y",
      "organization": "Decreases in circulating ANGPTL3/8 concentrations following retatrutide treatment parallel reductions in serum lipids.",
      "credentials": "",
      "logo": "/logos/medical.svg",
      "source": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12409240/",
      "source_type": "Peer-Reviewed (Abstract/Conclusion)",
      "verification_status": "Approved - Benefit-focused"
    },
    {
      "id": 1001,
      "peptide_name": "ARA-290",
      "quote": "ARA 290, a nonerythropoietic peptide engineered from erythropoietin, improves metabolic control and neuropathic symptoms in patients with type 2 diabetes.",
      "scientist": "Michael Brines",
      "organization": "Molecular Medicine (title statement)",
      "credentials": "MD",
      "logo": "/logos/medical.svg",
      "source": "https://link.springer.com/article/10.2119/molmed.2014.00215",
      "source_type": "Peer-Reviewed (Title)",
      "verification_status": "Curated - Human outcome (title statement)"
    }
  ]
}